Literature DB >> 22381825

Endoscopic third ventriculostomy for idiopathic aqueductal stenosis.

Pietro Spennato1, Sanna Tazi, Olivier Bekaert, Giuseppe Cinalli, Philippe Decq.   

Abstract

BACKGROUND: Idiopathic aqueductal stenosis is a cause of noncommunicating hydrocephalus, which actual treatment with endoscopic third ventriculostomy (ETV) could assess without any interference with the etiology. The results of ETV in this indication therefore could be interpreted as the result of the surgical procedure alone, without any additional factors related to the etiology of the cerebrospinal fluid pathway obstruction, such as hemorrhage, infection, brain malformations, or brain tumors or cysts.
METHODS: After a brief description of pathogenesis of hydrocephalus in aqueductal stenosis, the authors review the literature for studies on ETV, extrapolating patients with idiopathic aqueductal stenosis in infancy, childhood, and adulthood. Differences in outcome between patients treated with ETV and patients treated with ventriculoperitoneal shunt (VPS) are also reviewed.
RESULTS: The overall success rates of ETV range between 23% to 94%, with a mean of 68%; when only patients affected by obstructive triventricular hydrocephalus secondary to aqueductal stenosis are considered, the success rate is actually quite homogeneous and stable, being above 60% at any age, even if a trend in lower success rate in very young infants (younger than 6 months of age) is noticeable. The few reports on intellectual outcome failed to demonstrate differences between ETV and VPS.
CONCLUSIONS: Several issues, such as the cause of failures in well-selected patients, long-term outcome in infants treated with ETV, effects of persistent ventriculomegaly on neuropsychological developmental, remain unanswered. Larger and more detailed studies are needed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22381825     DOI: 10.1016/j.wneu.2012.02.007

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  8 in total

1.  Hydrocephalus in aqueductal stenosis--a retrospective outcome analysis and proposal of subtype classification.

Authors:  Imke Rodis; Cynthia Vanessa Mahr; Michael K Fehrenbach; Jürgen Meixensberger; Andreas Merkenschlager; Matthias K Bernhard; Stefan Schob; Ulrich Thome; Robin Wachowiak; Franz W Hirsch; Ulf Nestler; Matthias Preuss
Journal:  Childs Nerv Syst       Date:  2016-02-27       Impact factor: 1.475

2.  Exploring the efficacy of endoscopic ventriculostomy for hydrocephalus treatment via a multicompartmental poroelastic model of CSF transport: a computational perspective.

Authors:  John C Vardakis; Brett J Tully; Yiannis Ventikos
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

3.  Herpes simplex virus Type 1 encephalitis in an adolescent presenting with acute hydrocephalus.

Authors:  Marios S Themistocleous; Elias Antoniades; Dimitrios Giakoumettis; Aristoteles V Kalyvas; Andreas Mitsios; George Sfakianos
Journal:  J Surg Case Rep       Date:  2017-02-10

4.  Clinical analysis of aqueductal stenosis in patients with hydrocephalus in a Kenyan setting.

Authors:  Loyal Poonamjeet Kaur; Nderitu Joseph Munyiri; Wekesa Vincent Dismus
Journal:  Pan Afr Med J       Date:  2017-02-28

5.  Management of Obstructive Hydrocephalus in Pregnant Patient.

Authors:  Murat Şakir Ekşi; Ahmet Öğrenci; Osman Ersegun Batçık; Orkun Koban
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

6.  Implication of image guidance in endoscopic third ventriculostomy: Technical note.

Authors:  Muhammad Samir Irfan Wasi; Salman Yousuf Sharif; Farhan Gulzar
Journal:  Surg Neurol Int       Date:  2020-05-02

7.  Endoscopic Third Ventriculostomy: Role of Image Guidance in Reducing the Complications.

Authors:  Muhammad Samir Irfan Wasi; Salman Sharif; Yousuf Shaikh
Journal:  Asian J Neurosurg       Date:  2020-10-19

8.  Idiopathic Aqueductal Stenosis: Late Neurocognitive Outcome in ETV Operated Adult Patients.

Authors:  Matteo Martinoni; Giovanni Miccoli; Luca Albini Riccioli; Francesca Santoro; Giacomo Bertolini; Corrado Zenesini; Diego Mazzatenta; Alfredo Conti; Luigi Maria Cavallo; Giorgio Palandri
Journal:  Front Neurol       Date:  2022-04-07       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.